Migraine, patent foramen ovale and migraine triggers by unknown
Introduction
The presence of patent foramen ovale (PFO) may allow
venous blood to pass from the right atrium toward arterial
blood in the left atrium through the interatrial septum.
Although the incidence of any degree of PFO is high
among the general population, the analysis of this trait in
subjects with neurological diseases has raised interest in
recent years [1]. The prevalence of migraine in Western
countries is rather high, with some of these patients suf-
fering migraine with aura (MA). The focal phenomenon
that appears in MA is related to a phenomenon of propa-
gated cortical depression and may be triggered by various
stimuli, although the pathophysiology of aura and the
mechanism by which the stimuli trigger migraine attacks
are still unclear [2].
One of the neurological disorders in which an elevated
prevalence of PFO has been reported is MA. Some studies
have described an incidence of PFO in MA which is as high
as among patients with stroke of undetermined origin [3–5].
Nevertheless, it is unknown if this association is incidental
or if there is some connection or relationship. The interest
in clarifying these relationships is further raised, as inva-
sive techniques such as percutaneous closure of PFO is
questioned as a feasible therapy in these cases [6].
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Abstract Little information exists
about a causal association between
PFO and migraine. Some patients
identify Valsalva-provoking activities
(VPA) as migraine triggers.
Therefore, we speculate about a path-
ogenic connection. The object of the
study is to investigate the prevalence
of right-to-left shunt (RLS) in a
cohort of patients suffering migraine
with aura (MA) and its possible asso-
ciation with migraine attacks triggered
by VPA. We investigated the circum-
stances triggering the migraine
attacks, in a consecutive series of 72
MA patients and in a series of
migraine without aura age and gen-
der-matched.  The presence and extent
of RLS was assessed by transcranial
Doppler. Massive RLS appeared in
38.9% of MA and in 6.5% of
migraine without aura (p<0.001). MA
patients identified at least one VPA as
headache trigger in 45.8%. A trend
was found between these triggering
activities and massive RLS, both in
MA group OR 2.7 [1.02–7.17] and in
all migraine patients OR 2.5
[1.01–6.11]. According to our results,
patients with migraine who have larg-
er RLS tend to recognize activities
that increase the extent of the shunt as
a trigger of their migraine attacks.
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8Theoretically, some migraine triggers such as exercise or
exertion can cause Valsalva manoeuvres, thus increasing the
extent of right-to-left shunt (RLS) linked to PFO. If this
shunt were indeed related to the genesis of migraine attacks,
patients with MA and PFO might be able to recognise these
activities as triggers of their migraines. The purpose of our
study was to analyse a potential relationship between these
triggers, the presence of RLS and MA attacks.
Patients and methods
The study population consisted of patients diagnosed with MA
selected from specific outpatient visits for headaches, the first
patients being recruited in late 2002. All patients met IHS crite-
ria for migraine with typical aura [7]. Patients with a single
episode of aura were expressly excluded, even when they had a
history of migraine without aura. Less common forms of
migraine or probable MA (acute onset or prolonged aura) were
also excluded. As part of routine clinical practice, the patients
were surveyed to determine medical history and triggers of
migraine attacks. In particular, triggers included those common-
ly accepted, such as stress, sleep, changing weather, flashes of
light, specific foods and hormonal factors, as well as circum-
stances that induce Valsalva manoeuvres such as strenuous exer-
cise, exertion during bowel movements, weightlifting, sudden
standing, coughing or laughing crises, and sexual activity.
Informed consent was obtained from the patients as required by
the local ethics committee to perform a transcranial Doppler.
The transcranial Doppler was used to study the vessels of Willis’
polygon through the temporal window and specifically deter-
mining the presence/absence of RLS as described in the method
already published and used by other authors [8]. Briefly, agitat-
ed saline achieving a microbubble emulsion was injected
through an antecubital venous access. One of the middle cerebral
arteries was then simultaneously monitored by transcranial
Doppler and the presence of RLS was determined by the appear-
ance of transient high-intensity signals within the first 10 cardiac
cycles after injection of saline solution. These measurements
were repeated at baseline and after a controlled Valsalva
manoeuvre. The examination allowed confirmation of the pres-
ence of RLS, as well as semiquantitative classification of the
extent of the RLS. Patients with patterns of >25 or uncountable
signals after the Valsalva’s manoeuvre (“shower” or “curtain”
patterns) were defined as massive shunt [9].
Univariate analysis was used to determine the correlation
between the presence of RLS and MA. In addition, univariate
analysis was also employed in an attempt to identify the possible
relationship between triggers (classic and those specifically
investigated that produce Valsalva’s manoeuvre) and the pres-
ence or absence of RLS and the degree of shunt. We established
a level of alpha error at 0.05 for single comparisons and for the
subgroups analysis alpha was considered both at customary 0.05
and corrected for multiple comparisons at 0.025.
The same measurements were performed on a control series
of patients with migraine without aura.
Results
We included a total of 72 patients diagnosed with MA and
31 with migraine without aura. A total of 103 patients
were included with mean age 36±11.3 years; 36 men and
67 women. Mean age was 36±12 years (46 women, 26
men) among patients with MA and 37±9 years (21
women, 10 men) in those with migraine without aura. No
differences were found in age or distribution by sex
between patients with or without aura. The most relevant
data on medical history are shown in Table 1.
In the survey on crisis triggers in patients with MA,
stress was mentioned most often by 50 patients (69.4%), fol-
lowed by changes in sleep patterns (n=37, 51.4%) and
changing weather conditions (n=31, 43.1%). Strenuous
physical exercise was the most common situation leading to
Valsalva recognised as trigger, in 18 cases (25%). A total of
33 patients with MA (45.8%) reported at least one of these
Valsalva-provoking activities as the trigger for their crisis.
For the migraine without aura controls, the trigger
reported most often was stress by 29 patients (93.5%) fol-
lowed by changing weather and variations in sleep pat-
terns (n=18, 58.1%). Manoeuvres leading to Valsalva
were reported by 12 patients (38.7%). There were no dif-
ferences with respect to MA patients (Table 2).
RLS at baseline was found in 39 patients with MA,
54.1% of those analysed. After Valsalva’s manoeuvre, 44
(61.1%) patients showed positive RLS. In comparison with
patients with migraine without aura, RLS was always more
Table 1 Medical history
Heart diseases Respiratory diseases Hypertension Diabetes DVT* Smoker Contraceptives
MA† 3 (4.2%) 2 (2.8%) 10 (13.9%) 0 (0) 2 (2.8%) 24 (33.3%) 15 (20.8%)




9common in patients with MA, whether at baseline (39 vs. 6,
p<0.001) or after Valsalva’s manoeuvre (44 vs. 7, p<0.001).
The semiquantitative assessment was 38.9% massive RLS
in the MA group vs. 6.5% in the group without aura.
A meticulous analysis of patients who recognised situ-
ations potentially leading to a Valsalva manoeuvre as trig-
gers indicated the following:
a) Among MA patients: 24 patients recognising these
triggers showed positive RLS and 9 patients with these
triggers showed negative RLS. Despite a trend, this
difference was not statistically significant (p=0.063).
b) Among MA patients and considering the presence of
massive shunt: patients reporting these triggers were
more likely to have massive RLS (n=17, 51.5%). In
contrast, 28 patients (71%) did not recognise these
triggers and did not have massive shunt vs. 11 patients
(28.2%) without triggers and showing massive shunt
(OR 2.7, 95% CI [1.02–7.17], p=0.043).
c) When considering the entire sample, including patients
with and without aura, these differences also
remained. Therefore, among those reporting these trig-
gers massive shunt was found in 18 cases (40%) vs. 27
with lack of massive shunt (60%). Among patients
without these triggers there was a lack of massive RLS
in 46 cases (79.3%) vs. 12 cases (12.7%) lacking these
triggers and with massive RLS, for a prevalence of
massive shunt of 29.1% in all 103 patients (OR 2.5,
95% CI [1.01–6.11], p=0.032).
Discussion
The results of this study provide some support for a poten-
tial correlation between triggers, the presence of RLS and
migraine attacks. According to our results, patients with
migraine who have RLS tend to recognise activities that
can cause Valsalva’s manoeuvre, increasing the extent of
shunt as a trigger of their migraine attacks.
PFO is a vestige of foetal circulation that results from
a failure of the septum primum and secundum to fuse and
is present in a high percentage of the unselected adult pop-
ulation (27%) [10]. Since the initial comments of
Wilmshurst et al. [11, 12] on the elevated frequency of
PFO among scuba divers with decompression illness and
the improvement in migraine symptoms in those who had
undergone closure of the foramen ovale, several series and
studies on PFO and its relationship with neurological dis-
eases have been published [1].
Perhaps the most relevant aspect has been the elevated
frequency of PFO in stroke of undetermined cause [4,
13–15] and its recurrences [16, 17]. In fact, an association
between stroke, PFO and migraine has been reported [5, 18,
19]. Along with stroke, however, migraine and particularly
MA have been the focus of greater interest in studies on PFO.
The arguments put forth to support a connection
between the presence of PFO and the genesis of MA are
essentially the frequency of the association and the effects
of foramen closure on headaches. The elevated frequency
of PFO among patients with MA has been reported in var-
ious studies in recent years [4, 20] and interatrial septal
aneurysm has also been reported more often [21]. In our
study, RLS was found in 61% of the MA patients and 23%
of the migraine without aura patients, figures comparable
to those published in the literature. It is certainly striking
in our study that many patients had RLS classified as mas-
sive, i.e., with “shower” or “curtain” patterns linked to
significantly larger PFO. This finding has also been
reported with very similar figures in both transoe-
sophageal echocardiography studies [22], as well as tran-
scranial Doppler studies [3]. Nevertheless, the numeric
association does not imply causality.
According to most authors, the other basic reason for
defending the causal role of PFO in migraine is the
improvement in migraine after foramen ovale closure.
This improvement resulted in a decrease of 14%–80% in
the frequency of migraine attacks, depending on the
series, a decrease in the severity measured by disability
scales and even disappearance of the migraine attacks
and/or aura [23–27]. Our study cannot contribute anything
of interest in this regard as it is not an interventional study.
Many authors suggest that the association between
PFO and migraine is incidental and linked to hereditary
factors, with no direct link. A familial aggregation of PFO
among the relatives of patients with cryptogenic stroke
has been reported [28]. Several studies report a tendency
Table 2 Migraine triggers
Stress Weather Sleep Foods Valsalva Exercise >2 VPA*
MA† 50 (69.4%) 31 (43.1%) 37 (51.4%) 19 (26.4%) 33 (45.8%) 18 (25%) 10 (13.9%)
MwA‡ 29 (93.5%) 18 (58.1%) 18 (58.1%) 9 (29%) 12 (38.7%) 6 (19.4%) 4 (12.9%)
†Migraine with aura
‡Migraine without aura
*More than 2 Valsalva provoking activities
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to inherit both migraines and an interatrial septum defect,
and in fact the presence of septal defects appears to be
transmitted in a dominant autonomic manner and signifi-
cantly associated with MA [29], without this MA–PFO
association being significantly linked to the female sex
[30]. These findings sustain, in part, the hypothesis of a
genetically determined association which would include a
subgroup of MA associated to PFO, although no author
has demonstrated a mechanism that could relate them.
Elegant hypotheses suggest that the presence of PFO
may result in a shunt that sidesteps the pulmonary capillary
filter, thus allowing some component capable of initiating
the migraine attack to reach the central nervous system.
Interestingly, a high prevalence of migraine has also been
reported in patients with extracardiac shunts [31].
Wilmshurst and Nightingale recently provided a detailed
description of this scenario [32]. The migraine triggers
could be microembolisations from the venous territory
[12] or, more likely, some activated molecule or particle
that may elude the filtering or deactivation ability of the
lung parenchyma. This role of the lungs in migraine as a
filter is not new in the literature [33]. The candidate sub-
stance according to these authors would be the amines, in
particular 5-hydroxytryptamine (5-HT), which is implicat-
ed in the genesis of migraine [34] and probably a platelet
hyperactivation state already shown in the pathogenesis of
the migraine [35]. To complete this hypothesis the capaci-
ty of the pulmonary vessels to inactivate 5-HT has also
reported [36]. The series that report improvements in
migraines with antiplatelet agents support this theory in
part [37]. Whether or not the bypass resulting from PFO
triggers the migraine when a specific threshold is exceed-
ed or induces through chronic shunt a state of central
hyperexcitability affected by other triggers is a matter of
speculation. According to this scenario, patients with PFO
and migraine may recognise that daily life situations that
induce Valsalva manoeuvres do trigger crises by increasing
the extent of RLS. This hypothesis has already been men-
tioned in the theoretical literature, although the question
remains unanswered to our knowledge [38]. Our results
would support the role of RLS as a trigger in at least some
patients, due to the mechanisms mentioned. In addition,
this statement would be true for both MA (where the asso-
ciation is particularly prevalent for reasons not yet under-
stood) patients and for common migraine patients who
have significant RLS. Nevertheless, the results only indi-
cate a trend and the absence of a correlation would not
invalidate the initial hypothesis, as it is known that patients
with PFO experience shunt without pulmonary hyperten-
sion, both at rest and during activities as common as
coughing [39–41]. We should again mention the high num-
ber of patients in our study who presented significant shunt
at rest. In contrast to this theory, the preliminary results of
the first randomised trial on PFO closure in migraine
(MIST trial) did not achieve its primary endpoint for the
complete elimination of headache [42].
As in similar case-control studies, a selection bias can-
not be excluded and some patients with MA in particular,
when triggers exist, are more likely to show up in
headache clinics, although triggers were not the reason for
consultation in this particular series. During data collec-
tion patients were included consecutively without consid-
ering any characteristics, except for MA according to the
current diagnostic criteria. The control subjects were
selected to match such characteristics as mean age and
sex, and there were no significant differences in medical
history between the two groups. However, in order to min-
imise type two error and confounding results, the control
group should be increased and should be at least as large
as the MA group. Another systematic error that cannot be
ruled out in this design is recall bias when reporting trig-
gers, although triggers were routinely collected in the
medical interview prior to ultrasonographic study and
determination of RLS, in order to minimise this bias.
Finally, the type one level of error could be considered at
the routine 0.05 value or could be corrected for subgroup
analysis at 0.025 (Bonferroni method for multiple com-
parisons) in order to reduce spurious correlations. In our
opinion this correction is too conservative when testing
hypotheses using variables that are mutually correlated. In
this case-control, exploratory study this correction (with
correlated variables) might have increased the chance that
true associations would not be discovered.
In conclusion, our study adds some information that
supports the PFO–migraine connection, but this associa-
tion remains, on the whole, unexplained. We consider it to
be of maximum interest to answer a variety of questions:
Is it an aetiological or accidental relation? What is the
exact mechanism? and essentially, Could any new thera-
peutic procedure be justified?
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